Es gab 50 kürzliche Insider-Transaktionen für Sutro Biopharma, Inc. (STRO), darunter 32 Käufe und 15 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $796.23K und die gesamten Insider-Verkäufe auf $76.16K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Chung Jane, Pauling David, Chow Gregory K.. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — STRO
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-04 |
Chung Jane |
Chief Executive Officer |
Optionsausübung (Verkauf) |
788 |
- |
- |
- |
| 2026-03-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Optionsausübung (Verkauf) |
675 |
- |
- |
- |
| 2026-03-02 |
Chow Gregory K. |
CFO |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2026-03-02 |
Chung Jane |
Chief Executive Officer |
RSU-Steuereinbehalt |
2,779 |
$20.55 |
$57.11K |
20,779 |
| 2026-03-02 |
Gerber Hans-peter |
Chief Scientific Officer |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2026-03-02 |
Pauling David |
Chief Admin. Ofcr. & Gc |
RSU-Zuteilung |
4,200 |
- |
- |
4,200 |
| 2026-03-01 |
Chung Jane |
Chief Executive Officer |
Optionsausübung (Verkauf) |
688 |
- |
- |
688 |
| 2026-03-01 |
Gerber Hans-peter |
Chief Scientific Officer |
Optionsausübung (Verkauf) |
1,125 |
- |
- |
2,250 |
| 2026-03-01 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Optionsausübung (Verkauf) |
500 |
- |
- |
500 |
| 2025-12-23 |
Panek James P |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Matsui Connie |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Petree Daniel H |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Lobacki Joseph M |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Jagpal Sukhi |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Wigginton Jon Marc |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Dybbs Michael |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Chow Gregory K. |
CFO |
RSU-Zuteilung |
8,200 |
$10.38 |
$85.12K |
8,200 |
| 2025-12-23 |
Hunter Heidi |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Gerber Hans-peter |
Chief Scientific Officer |
RSU-Zuteilung |
7,925 |
$10.38 |
$82.26K |
7,925 |
| 2025-12-23 |
Pauling David |
Chief Admin. Ofcr. & Gc |
RSU-Zuteilung |
7,200 |
$10.38 |
$74.74K |
7,200 |
| 2025-12-12 |
Chung Jane |
Chief Executive Officer |
Optionsausübung (Verkauf) |
2,500 |
- |
- |
5,000 |
| 2025-10-15 |
Matsui Connie |
Director |
Informierter Kauf |
50,000 |
$0.80 |
$39.95K |
50,000 |
| 2025-10-15 |
Chow Gregory K. |
CFO |
Informierter Kauf |
19,750 |
$0.81 |
$16K |
19,750 |
| 2025-10-15 |
Chung Jane |
Chief Executive Officer |
Informierter Kauf |
12,500 |
$0.80 |
$10.01K |
122,850 |
| 2025-10-15 |
Gerber Hans-peter |
Chief Scientific Officer |
Informierter Kauf |
17,000 |
$0.80 |
$13.61K |
71,832 |
| 2025-10-15 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Informierter Kauf |
12,504 |
$0.80 |
$9.99K |
71,737 |
| 2025-09-18 |
Gerber Hans-peter |
Chief Scientific Officer |
RSU-Steuereinbehalt |
13,417 |
$0.90 |
$12.08K |
54,832 |
| 2025-08-09 |
Chung Jane |
Chief Executive Officer |
Optionsausübung (Verkauf) |
18,750 |
- |
- |
- |
| 2025-07-08 |
Leyman Barbara |
Chief Business Officer |
RSU-Steuereinbehalt |
8,944 |
$0.78 |
$6.98K |
16,056 |
| 2025-06-06 |
Panek James P |
Director |
RSU-Zuteilung |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Matsui Connie |
Director |
RSU-Zuteilung |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Petree Daniel H |
Director |
RSU-Zuteilung |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Lobacki Joseph M |
Director |
RSU-Zuteilung |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Jagpal Sukhi |
Director |
RSU-Zuteilung |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Wigginton Jon Marc |
Director |
RSU-Zuteilung |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Dybbs Michael |
Director |
RSU-Zuteilung |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Hunter Heidi |
Director |
RSU-Zuteilung |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-02 |
Chow Gregory K. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-06-02 |
Chow Gregory K. |
CFO |
RSU-Zuteilung |
100,000 |
- |
- |
100,000 |
| 2025-05-15 |
Albini Edward C |
CFO and Secretary |
Optionsausübung (Verkauf) |
9,125 |
- |
- |
- |
| 2025-05-01 |
Fitzpatrick Linda A |
Chief People & Comm. Officer |
Optionsausübung (Verkauf) |
9,125 |
- |
- |
- |
| 2025-05-01 |
Borgman Anne Elizabeth |
Chief Medical Officer |
Optionsausübung (Verkauf) |
15,938 |
- |
- |
17,812 |
| 2025-05-01 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
Optionsausübung (Verkauf) |
2,500 |
- |
- |
5,000 |
| 2025-04-11 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
Optionsausübung (Verkauf) |
21,250 |
- |
- |
21,250 |
| 2025-04-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Unbekannt |
- |
- |
- |
56,733 |
| 2025-04-04 |
Chung Jane |
Chief Executive Officer |
RSU-Zuteilung |
310,000 |
- |
- |
310,000 |
| 2025-04-04 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
RSU-Zuteilung |
94,250 |
- |
- |
94,250 |
| 2025-04-04 |
Gerber Hans-peter |
Chief Scientific Officer |
RSU-Zuteilung |
113,750 |
- |
- |
113,750 |
| 2025-04-04 |
Leyman Barbara |
Chief Business Dev. Officer |
RSU-Zuteilung |
84,500 |
- |
- |
84,500 |
| 2025-04-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Unbekannt |
25,275 |
- |
- |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
